JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB51045

Anti-HSD17B1 antibody [EP1682Y]

Be the first to review this product! Submit a review

|

(20 Publications)

Rabbit Recombinant Monoclonal HSD17B1 antibody. Suitable for IHC-P, IP, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 20 publications.

View Alternative Names

E17KSR, EDH17B1, EDH17B2, EDHB17, SDR28C1, HSD17B1, 17-beta-hydroxysteroid dehydrogenase type 1, 17-beta-HSD 1, 20 alpha-hydroxysteroid dehydrogenase, E2DH, Estradiol 17-beta-dehydrogenase 1, Placental 17-beta-hydroxysteroid dehydrogenase, Short chain dehydrogenase/reductase family 28C member 1, 20-alpha-HSD

5 Images
Flow Cytometry (Intracellular) - Anti-HSD17B1 antibody [EP1682Y] (AB51045)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-HSD17B1 antibody [EP1682Y] (AB51045)

Overlay histogram showing JEG3 cells stained with ab51045 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab51045, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HSD17B1 antibody [EP1682Y] (AB51045)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HSD17B1 antibody [EP1682Y] (AB51045)

ab51045 (1/100 dilution) staining human HSD17B1 in paraffin embedded human placenta tissue by Immunohistochemistry.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Immunoprecipitation - Anti-HSD17B1 antibody [EP1682Y] (AB51045)
  • IP

Lab

Immunoprecipitation - Anti-HSD17B1 antibody [EP1682Y] (AB51045)

Purified ab51045 at 1/50 dilution (2μg) immunoprecipitating HSD17B1 in Human placenta lysate.
Lane 1 (input) : Human placenta lysate 10μg
Lane 2 (+) : ab51045 + Human placenta lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab51045 in Human placenta lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 34 kDa

All lanes:

Immunoprecipitation - Anti-HSD17B1 antibody [EP1682Y] (ab51045)

Predicted band size: 35 kDa

false

Western blot - Anti-HSD17B1 antibody [EP1682Y] (AB51045)
  • WB

Unknown

Western blot - Anti-HSD17B1 antibody [EP1682Y] (AB51045)

All lanes:

Western blot - Anti-HSD17B1 antibody [EP1682Y] (ab51045) at 1/100000 dilution

All lanes:

Human placenta tissue lysate at 10 µg

Secondary

All lanes:

Goat anti-Rabbit HRP labeled at 1/2000 dilution

Predicted band size: 35 kDa

Observed band size: 35 kDa

false

Western blot - Anti-HSD17B1 antibody [EP1682Y] (AB51045)
  • WB

CiteAb

Western blot - Anti-HSD17B1 antibody [EP1682Y] (AB51045)

HSD17B1 western blot using anti-HSD17B1 antibody [EP1682Y] ab51045. Publication image and figure legend from Aka, J. A., Zerradi, M., et al., 2012, Breast Cancer Res, PubMed 22691413.

ab51045 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab51045 please see the product overview.

Proteomic analysis of wild type (WT) MCF7 cells and MCF7 cells stably transfected with 17β-HSD1 (MCF7-17βHSD1). (A) 17beta-hydroxysteroid dehydrogenase type 1 (17β-HSD1) and β-actin expression between WT MCF7 and MCF7-17βHSD1 revealed by western blots. (B) Representative two-dimensional gel images for WT MCF7 and MCF7-17βHSD1 cells. Whole cell lysates (200 μg) from each cell were separated by two-dimensional electrophoresis and visualized by Sypro Ruby staining. The two-dimensional gels were scanned and the differentially expressed (2-fold or higher, p < 0.05) proteins were detected using Progenesis software. The 18 differentially expressed protein spots that were selected for mass spectrometry (MS) analysis are marked with circles. Protein spots upregulated in MCF7-17βHSD1 are depicted in the MCF7-17βHSD1 proteome image; protein spots downregulated in MCF7-17βHSD1 are depicted in the MCF7 proteome image. The numbers refer to the spot number listed in Table 1 and Additional file 2. The squares represent the indicated area shown in more detail in (D). (C) Summary of the numbers of spots and proteins obtained from the proteomics data. *Upregulated (up) and downregulated (down) proteins in MCF7-17βHSD1 as compared to WT MCF7 cells. (D) Zoom showing some differentially expressed protein spots from WT MCF7 and MCF7-17βHSD1 comparison. Arrows indicate 17β-HSD1 protein which was revealed by MS analysis to be present in the spot numbers 2,305 (unique to MCF7-17βHSD1) and 2,300 (upregulated in MCF7-17βHSD1 as compared to WT MCF7 cells).

false

  • Carrier free

    Anti-HSD17B1 antibody [EP1682Y] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP1682Y

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

Flow Cyt (Intra), IP, WB, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/50", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1 µg for 10^6 Cells", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" } } }

Product details

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine, 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Favors the reduction of estrogens and androgens. Converts estrone (E1) to a more potent estrogen, 17beta-estradiol (E2) (PubMed : 8994190). Also has 20-alpha-HSD activity. Uses preferentially NADH.
See full target information HSD17B1

Publications (20)

Recent publications for all applications. Explore the full list and refine your search

Biomolecules 14: PubMed39199376

2024

The Role of MALAT1 in Regulating the Proangiogenic Functions, Invasion, and Migration of Trophoblasts in Selective Fetal Growth Restriction.

Applications

Unspecified application

Species

Unspecified reactive species

Shuting Xia,Yingnan Ye,Jialiu Liu,Hanfei Qiu,Minhuan Lin,Zhiming He,Linhuan Huang,Malie Wang,Yanmin Luo

Frontiers in endocrinology 14:1268248 PubMed37964966

2023

Expression of genes and enzymes involved in ovarian steroidogenesis in relation to human follicular development.

Applications

Unspecified application

Species

Unspecified reactive species

Mengxue Zheng,Claus Yding Andersen,Frida Roikjer Rasmussen,Jesús Cadenas,Søren Tvorup Christensen,Linn Salto Mamsen

Reproductive biology and endocrinology : RB&E 20:126 PubMed35986324

2022

Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM.

Applications

Unspecified application

Species

Unspecified reactive species

Jesús Cadenas,Susanne Elisabeth Pors,Ajay Kumar,Bhanu Kalra,Stine Gry Kristensen,Claus Yding Andersen,Linn Salto Mamsen

The Journal of clinical endocrinology and metabolism 107:e3374-e3383 PubMed35511085

2022

Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries.

Applications

Unspecified application

Species

Unspecified reactive species

Stine Gry Kristensen,Ajay Kumar,Linn Salto Mamsen,Bhanu Kalra,Susanne Elisabeth Pors,Jane Alrø Bøtkjær,Kirsten Tryde Macklon,Jens Fedder,Erik Ernst,Kate Hardy,Stephen Franks,Claus Yding Andersen

Frontiers in molecular biosciences 9:854991 PubMed35591944

2022

Site-Specific Regulation of Sulfatase and Aromatase Pathways for Estrogen Production in Endometriosis.

Applications

Unspecified application

Species

Unspecified reactive species

Katiane de Almeida Da Costa,Helena Malvezzi,Cristine Dobo,Rosa Maria Neme,Renée Zon Filippi,Thiago Pinheiro Arrais Aloia,Elisa Rampazo Prado,Juliana Meola,Carla de Azevedo Piccinato

Methods and protocols 5: PubMed35448699

2022

Capillary Western Immunoassay Optimization of Estrogen Related Factors in Human Subcutaneous Adipose Tissue.

Applications

Unspecified application

Species

Unspecified reactive species

Jessica L Hill,Kara B McIver,Kaleigh Katzer,Michelle T Foster

Reproductive biology and endocrinology : RB&E 18:119 PubMed33225937

2020

Establishment of an immortalized stromal cell line derived from human Endometriotic lesion.

Applications

Unspecified application

Species

Unspecified reactive species

Zhi-Xiong Huang,Rong-Feng Wu,Xiao-Mei Mao,Shao-Min Huang,Tian-Tian Liu,Qiong-Hua Chen,Qing-Xi Chen

Nanomaterials (Basel, Switzerland) 10: PubMed32635405

2020

Uptake of Cerium Dioxide Nanoparticles and Impact on Viability, Differentiation and Functions of Primary Trophoblast Cells from Human Placenta.

Applications

Unspecified application

Species

Unspecified reactive species

Margaux Nedder,Sonja Boland,Stéphanie Devineau,Amal Zerrad-Saadi,Jasmina Rogozarski,René Lai-Kuen,Ibtissem Baya,Jean Guibourdenche,Francoise Vibert,Audrey Chissey,Sophie Gil,Xavier Coumoul,Thierry Fournier,Ioana Ferecatu

Placenta 83:57-62 PubMed31477209

2019

Potential role of microRNA-424 in regulating ERRγ to suppress trophoblast proliferation and invasion in fetal growth restriction.

Applications

Unspecified application

Species

Unspecified reactive species

Zhiyong Zou,Zhiming He,Jian Cai,Linhuan Huang,Hui Zhu,Yanmin Luo

Drug design, development and therapy 13:757-766 PubMed30863015

2019

siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo.

Applications

Unspecified application

Species

Unspecified reactive species

Fang Li,ZhiHan Zhu,Man Xue,WanHong He,Ting Zhang,LingLin Feng,ShengXiang Lin
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com